In our investigations we did not determine AAG, which is not a marker commonly used in clinical practice in our country, and prealbumin due to its susceptibility to nutrition inhibition, which always occurs in the course of the treatment of AM patients. The gene discussed is TTR; the disease is acute myeloblastic leukemia with maturation.